ViaPharma s.r.o.
ViaPharma s.r.o. is a Czech pharmaceutical distributor operating three GDP-compliant distribution centers (Pavlov u Kladna, Brno, Ostrava) under Penta Investments ownership, supplying pharmacies, hospitals, and specialized healthcare facilities across the Czech Republic on a regulated 8% trade margin.
- Company typePrivate
- Founded2013
- HeadquartersPrague, Czechia
- Headcount11–50
- GTM typeB2B
- OfferingServices
What ViaPharma s.r.o. does
ViaPharma s.r.o. is a private Czech pharmaceutical distributor operating exclusively in the Czech Republic under owner Penta Investments, which acquired the business (then Gehe Pharma) from Celesio in October 2013 and rebranded it. The company operates three modern, GDP-compliant distribution centers in Pavlov u Kladna (Prague area), Brno, and Ostrava, providing nationwide coverage. Its core product is B2B pharmaceutical distribution to pharmacies, hospitals, hospital pharmacies, reproductive medicine clinics, hospices, and senior care facilities, with the Dr. Max pharmacy chain acting as the primary anchor customer under common Penta ownership.
ViaPharma's offering is unified under Good Distribution Practice (EU GDP) compliance, which ensures medicinal products maintain required properties throughout the supply chain. Supporting the core distribution service, the company operates a Klientská zóna (Client Zone) electronic ordering system and a C-Link electronic communication integration for hospitals and hospital pharmacies, enabling direct order management and delivery document exchange. Logistics is delivered via ViaPharma's own warehouse operations and a strategic partnership with DHL for transportation, with extended evening expedition hours at the Pavlov distribution center supporting high-frequency fulfillment.
The revenue model is a regulated transaction-based margin: a standardized 8% trade margin (OPD) on pharmaceutical products, plus transactional fees for freight (180 CZK excl. VAT for single orders) and contractual penalties for non-returned transport packaging (250 CZK per item). Pricing is anchored by Czech law — for products where regulations cap the margin, the regulatory maximum applies. Go-to-market is enterprise B2B field sales: dedicated hospital Key Account Managers (e.g., KAM Hospital Morava), a phone-based ordering department, and a credit-checked onboarding process for regular customers with tiered payment terms (prepayment, 15 days, or 30 days) based on monthly volume tiers of up to 500K, 1M, or above 1M CZK.
ViaPharma s.r.o. firmographics
Firmographics- Name
- ViaPharma s.r.o.
- Legal name
- ViaPharma s.r.o.
- Website
- https://viapharma.cz
- Company type
- Private
- Founded year
- 2013
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- ViaPharma s.r.o. is a Czech pharmaceutical distributor operating three GDP-compliant distribution centers (Pavlov u Kladna, Brno, Ostrava) under Penta Investments ownership, supplying pharmacies, hospitals, and specialized healthcare facilities across the Czech Republic on a regulated 8% trade margin.
- Ownership category
- akta.pro rank
ViaPharma s.r.o. industry classification
Industry- Product category
- Pharmaceutical Distribution
- NAICS
- Drugs and Druggists' Sundries Merchant Wholesalers (42421)
- SIC
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
- akta.pro primary industry
- Hospital & Health-System Pharmaceutical Distributors (HLAIAJAD)
Keywords
Where ViaPharma s.r.o. is headquartered
LocationHeadquarters
- HQ city
- Prague
- HQ country
- Czechia
- HQ region
- Europe
Offices4 records
Markets served
ViaPharma s.r.o. business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Supply Chain, Personnel, Operations, Infrastructure, Technology or R&D
Revenue model
- Pharmaceutical Distribution Margin: ViaPharma generates revenue through a standardized trade margin (OPD - obchodní přirážka) of 8% on pharmaceutical products. For single-order customers, prepayment is required and freight charges of 180 CZK excl. VAT apply. Regular customers negotiate individual business terms based on monthly volume.
- Contractual Penalties and Fees: Revenue from contractual penalties for non-return of transport packaging (250 CZK per non-returned, damaged, or incomplete packaging).
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Transaction based/ take rate | Pay-as-you-go | Single/one-time order pricing |
| Transaction based/ take rate | Monthly | Regular customer - volume tier 1 |
| Transaction based/ take rate | Monthly | Regular customer - volume tier 2 |
| Transaction based/ take rate | Monthly | Regular customer - volume tier 3 |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels3 records
ViaPharma s.r.o. product offering
Product offeringCore offering
ViaPharma s.r.o. is a wholesale pharmaceutical distributor that procures medicinal products and distributes them to pharmacies, hospitals, reproductive clinics, hospices, and senior care homes across the Czech Republic. Distribution operates through three modern regional distribution centers (Pavlov u Kladna, Brno, Ostrava) supported by an electronic ordering portal (Klientská zóna) and C-Link electronic communication for hospital customers.
Product overview
ViaPharma s.r.o. is a pharmaceutical distributor operating a unified distribution service with an integrated electronic ordering platform. The core offering consists of pharmaceutical distribution services delivered through three distribution centers in Pavlov u Kladna, Brno, and Ostrava, supported by the Klientská zóna (Client Zone) ordering system and C-Link electronic communication for hospitals. The ViaPharma – Partner Vaší nemocnice program extends the service as a hospital partnership sub-brand. All services are unified under Good Distribution Practice compliance to ensure product quality.
Differentiator
Problem solved
Functional benefit
Products and services
- Pharmaceutical Distribution Services Core wholesale distribution of medicinal products to pharmacies, hospitals, reproductive clinics, hospices, and senior care homes across the Czech Republic. Operates through three modern distribution centers and supports regular customers with negotiated business terms based on monthly volume tiers, plus single-order purchasing with prepayment and freight fees.
Quantifiable outcome
- Products delivered at the right time, in the right place, and in the right quality
Companies that use ViaPharma s.r.o.
Customer profileNamed customers6 records
Segments3 records
Ideal customer profiles4 records
ViaPharma s.r.o. technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
ViaPharma s.r.o. partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- DHL (Czech Republic)coreViaPharma partners with DHL for pharmaceutical product transportation and delivery services. DHL handles the physical distribution of medicines from ViaPharma's distribution centers to pharmacies and hospitals, providing reliable logistics infrastructure for the pharmaceutical supply chain.
Scale indicators4 records
Recent moves8 records
Expansion highlights4 records
ViaPharma s.r.o. competitors and assessment
Company assessmentOthers
- Pilulka.cz: Czech online pharmacy and health-product retailer. Adjacent channel participant rather than a wholesale competitor, but represents an evolving pharmacy distribution endpoint that interacts with ViaPharma's supply chain.
- Dr. Max: Largest pharmacy chain in Central Europe and ViaPharma's primary customer; both are owned by Penta Investments. Related-entity ecosystem player rather than a direct competitor, but central to ViaPharma's revenue base and supply-chain dynamics.
- Penta Hospitals: Czech hospital operator also owned by Penta Investments. Sister company under common PE ownership with strategic relevance to ViaPharma's hospital distribution business via the 'Partner Vaší nemocnice' program.
- DHL Supply Chain (Czech Republic): ViaPharma's stated strategic logistics partner for pharmaceutical transportation in Czech Republic. Logistics ecosystem enabler rather than a competitor, but central to ViaPharma's delivery capability.
- Zentiva: Major Czech and pan-European generic pharmaceutical manufacturer headquartered in Prague. Not a competitor, but a key manufacturer-supplier relationship that channels product through ViaPharma's distribution network to Czech pharmacies and hospitals.
Direct peers
- Phoenix Group: Pan-European pharmaceutical wholesaler and pharmacy operator headquartered in Germany, with extensive Central and Eastern European operations including the Czech Republic. Directly comparable as a pharma distribution competitor serving pharmacies and hospitals across multiple CEE markets.
- Alliance Healthcare Czech Republic: Wholesale and retail pharmaceutical distribution business of Walgreens Boots Alliance operating in the Czech Republic. Direct competitor in pharma wholesale serving pharmacies, hospitals, and other healthcare providers.
Broad incumbents
- Celesio / McKesson Europe: Former parent company of ViaPharma (when it operated as Gehe Pharma) and one of Europe's largest pharmaceutical distributors and pharmacy operators. Comparable as a much larger incumbent with broader geographic footprint and manufacturer bargaining power.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
ViaPharma s.r.o. social profiles
Digital presenceViaPharma s.r.o. financial estimates
Financial estimateRevenue estimate
Valuation estimate
ViaPharma s.r.o. leadership team
Management profileNumber of profiles
Profiles5 records
ViaPharma s.r.o. funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
ViaPharma s.r.o. M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about ViaPharma s.r.o.
What does ViaPharma s.r.o. do?
ViaPharma s.r.o. is a wholesale pharmaceutical distributor that procures medicinal products and distributes them to pharmacies, hospitals, reproductive clinics, hospices, and senior care homes across the Czech Republic. Distribution operates through three modern regional distribution centers (Pavlov u Kladna, Brno, Ostrava) supported by an electronic ordering portal (Klientská zóna) and C-Link electronic communication for hospital customers.
Is ViaPharma s.r.o. a public or private company?
ViaPharma s.r.o. is a private company. It is classified as private equity controlled and is currently operating.
When was ViaPharma s.r.o. founded?
ViaPharma s.r.o. was founded in 2013. It employs 11 to 50 people.
Where is ViaPharma s.r.o. based?
ViaPharma s.r.o. is headquartered in Prague, Czechia, in the Europe region.
How does ViaPharma s.r.o. make money?
Two revenue lines are on record. Pharmaceutical Distribution Margin is the primary driver. The others are contractual Penalties and Fees.
Who are ViaPharma s.r.o.'s main competitors?
Others on record are Pilulka.cz, Dr. Max, Penta Hospitals, DHL Supply Chain (Czech Republic) and Zentiva. Direct peers are Phoenix Group and Alliance Healthcare Czech Republic. Celesio / McKesson Europe is listed as a broad incumbent.
Does ViaPharma s.r.o. have an API?
No public API is recorded for ViaPharma s.r.o..
What industry is ViaPharma s.r.o. in?
ViaPharma s.r.o.'s product category is Pharmaceutical Distribution. Its primary akta.pro industry code is HLAIAJAD, Hospital & Health-System Pharmaceutical Distributors. Its NAICS code is 42421 and its SIC code is 5122.